Objective: The aim of this study was to investigate the presence of human cytomegalovirus (HCMV) and Epstein-Barr virus (EBV) in the tissue of chronic periapical lesions, and to compare the results in relation to the symptoms of patients and the size of the lesion. Methods: Periapical lesions analyzed in the study were collected from the roots of the teeth indicated for extraction. Samples were divided according to the symptoms into groups of symptomatic and asymptomatic, and according the size into groups of small and large lesions. Polymerase chain reaction was used to detect HCMV and EBV. The amplification was performed in a DNA Thermal Cycler (Hybaid). Results: Symptomatic lesions were 7.68 times more likely to be infected with HCMV than asymptomatic lesions (p < 0.001). Large symptomatic lesions were 73.50 times more likely to harbor HCMV than small symptomatic lesions (p < 0.001). Large symptomatic lesions were 7.64 times more likely to be infected with EBV than small symptomatic lesions (p = 0.05). Large symptomatic lesions were 5.38 times more likely to harbor dual HCMV/EBV infection than small symptomatic lesions (p = 0.115). Conclusion: Detection of HCMV and EBV in the samples of periapical lesions suggests an important role of herpesviruses in periapical tissue destruction.

Keywords:
Human cytomegalovirus, Epstein-Barr virus, Periapical lesions, Polymerase chain reaction
1.
Márton IJ, Kiss C: Protective and destructive immune reactions in apical periodontitis. Oral Microbiol Immunol 2000;15:139-150.
2.
Nair PNR: Pathogenesis of apical periodontitis and the causes of endodontic failures. Crit Rev Oral Biol Med 2004;15:348-381.
3.
Stashenko P: Role of immune cytokines in the pathogenesis of periapical lesions. Endod Dent Traumatol 1990;6:89-96.
4.
Marton IJ, Kiss C: Characterization of inflammatory cell infiltrate in dental periapical lesions. Int Endod J 1993;26:131-136.
5.
Lukic A, Danilovic V, Petrovic R: Comparative immunohistochemical and quantitative analysis of inflammatory cells in symptomatic and asymptomatic chronic periapical lesions (in Serbian). Vojnosanit Pregl 2008;65:435-440.
6.
Liapatas S, Nakou M, Rontogianni D: Inflammatory infiltrate of chronic periradicular lesions: an immunohistochemical study. Int Endod J 2003;36:464-471.
7.
Andric M, Milasin J, Jovanovic T, Todorovic L: Human cytomegalovirus is present in odontogenic cysts. Oral Microbiol Immunol 2007;22:347-351.
8.
Contreras A, Umeda M, Chen C, Bakker I, Morrison JL, Slots J: Relationship between herpesviruses and adult periodontitis and periodontopathic bacteria. J Periodontol 1999;70:478-484.
9.
Hadinoto V, Shapiro M, Chi Sun C, Thorley-Lawson DA: The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PloS Pathog 2009;5:1-15.
10.
Hernádi K, Szalmas A, Mogyorosi R, Czompa L, Veress G, Csoma E, Marton I, Konya J: Prevalence and activity of Epstein-Barr virus and human cytomegalovirus in symptomatic and asymptomatic apical periodontitis lesions. J Endod 2010;36:1485-1489.
11.
Siquiera JF Jr, Rôças IN: PCR methodology as a valuable tool for identification of endodontic pathogens. J Dent 2003;31:333-339.
12.
Aitken C, Sengupta SK, Aedes C, et al: Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus. J Gen Virol 1994;75:95-100.
13.
Parra B, Slots J: Detection of human viruses in periodontal pockets using polymerase chain reaction. Oral Microbiol Immunol 1996;11:289-293.
14.
Meyer-König U, Haberland M, von Laer D, et al: Intragenic variability of human cytomegalovirus glycoprotein B in clinical strains. J Infect Dis 1998;177:1162-1169.
15.
Jakovljevic A, Andric M: Human cytomegalovirus and Epstein-Barr virus in etiopathogenesis of apical periodontitis: a systematic review. J Endod 2014;40:6-15.
16.
Michelson S: Human cytomegalovirus escape from immune detection. Intervirology 1999;42:301-307.
17.
Boeckh M, Nichols WG: Immunosuppressive effects of beta-herpesviruses. Herpes 2003;10:12-16.
18.
Hopkins HA, Monick MM, Hunninghake GW: Cytomegalovirus inhibits CD14 expression on human alveolar macrophages. J Infect Dis 1996;174:69-74.
19.
Slots J, Nowzari H, Sabeti M: Cytomegalovirus infection in symptomatic periapical pathosis. Int Endod J 2004;37:519-524.
20.
Walton R, Fouad A: Endodontic interappointment flare-ups: a prospective study of incidence and related factors. J Endod 1992;18:172-177.
21.
Imura N, Zuolo ML: Factors associated with endodontic flare-ups: a prospective study. Int Endod J 1995;28:261-265.
22.
Sabeti M, Simon JH, Slots J: Cytomegalovirus and Epstein-Barr virus are associated with symptomatic pariapical pathosis. Oral Microbiol Immunol 2003;18:327-328.
23.
Ozbek A, Ozbek SM: Detection of herpesviruses and human papillomavirus in acute apical abscesses by real-time PCR. Clin Oral Invest 2015;19:343-347.
24.
Sabeti M, Slots J: Herpesviral-bacterial coinfection in periapical pathosis. J Endod 2004;30:69-72.
25.
Sabeti M, Valles Y, Nowzari H, Simon JH, Keramani-Arab V, Slots J: Cytomegalovirus and Epstein-Barr virus DNA transcription in endodontic symptomatic lesions. Oral Microbiol Immunol 2003;18:104-108.
26.
Yildirim S, Yapar M, Kubar A, Slots J: Human cytomegalovirus, Epstein-Barr virus and bone resorption-inducing cytokines in periapical lesions of deciduous teeth. Oral Microbiol Immunol 2006;21:107-111.
27.
Verdugo F, Castillo A, Simonian K, Castillo F, Farez-Vidal E, D'Addona A: Periodontopathogen and Epstein-Barr virus-associated periapical periodontitis may be the source of retrograde infectious peri-implantitis. Clin Implant Dent Relat Res 2015;17:199-207.
28.
Yazdi KA, Sabeti M, Jabalameli F, Eman eini M, Kolahdouzan SA, Slots J: Relationship between human cytomegalovirus transcription and symptomatic apical periodontitis in Iran. Oral Microbiol Immunol 2008;23:510-514.
29.
Sabeti M, Simon JH, Nowzari H, Slots J: Cytomegalovirus and Epstein-Barr virus active infection in periapical lesions of teeth with intact crowns. J Endod 2003;29:321-323.
30.
Aalto SM, Linnavuori K, Peltola H, Vuori E, Weissbrich B, Schubert J, Hedman L, Hedman K: Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol 1998;56:186-191.
31.
Chalabi M, Moghim S, Mogharehabed A, Najafi F, Rezaie F: EBV and CMV in chronic periodontitis: a prevalence study. Arch Virol 2008;153:1917-1919.
32.
Chen V, Chen Y, Li H, Kent K, Baumgartner JC, Machida CA: Herpesviruses in abscesses and cellulitis of endodontic origin. J Endod 2009;35:182-188.
33.
Slots J: Herpesviruses in periodontal diseases. Periodontol 2000 2005;38:33-62.
34.
Verdugo F, Castillo A, Castillo F, Uribarri A: Epstein-Barr virus associated peri-implantitis: a split-mouth study. Clin Oral Invest 2015;19:535-543.
35.
Rosaline H, Satish ES, Kandaswamy D: Detection of presence or absence of herpes simplex virus, Epstein Barr virus and human cytomegalovirus in infected pulp using a polymerase chain reaction. Aust Endod J 2009;35:9-12.
36.
Odumade OA, Hogquist KA, Balfour HH Jr: Progress and problems in understanding and managing primary Epstein-Barr virus infectons. Clin Microbiol Rev 2011;24:193-209.
37.
Slots J, Sabeti M, Simon JH: Herpesviruses in periapical pathosis: an etiopathogenic relationship? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:327-331.
38.
Ferreira DC, Rochas IN, Paiva SS, Carmo FL, Cavalcante FS, Rosado AS, Santos KR, Siquiera JF: Viral-bacterial associations in acute apical abscesses. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:264-271.
39.
Ferreira DC, Paiva SS, Carmo FL, Rochas IN, Rosado AS, Santos KR, Siquiera JF: Identification of herpesvirus 1 to 8 and human papillomavirus in acute apical abscesses. J Endod 2011;37:10-16.
40.
Sunde PT, Olsen I, Enersen M, Grinde B: Patient with severe periodontitis and subgingival Epstein-Barr virus treated with antiviral therapy. J Clin Virol 2008;42:176-178.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.